Enavate Sciences GP, LLC → Camp4 Therapeutics Corp CAMP

Stake: 8.10% Shares: 3,785,802 CUSIP: 13463J101 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Item 4 of the Statement is amended and supplemented as follows: Effective September 9, 2025, James P. Boylan resigned from the Board of Directors of the Issuer.

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-08-31

DTC 4.16

1,186,689 shares short · -7.0% vs prior

Post-Filing Returns · since 2025-09-11 on CAMP

+1 day

+16.9%

+5 days

-0.4%

+30 days

+30.2%

+60 days

+49.6%

+90 days

+105.8%

+180 days

+117.6%

Anchor price 2.78 on closest trading day on/after 2025-09-11. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-31	Gold Kelly	officer	Buy	10,000	$3.96	$40K

Other 13D/G Filings on Camp4 Therapeutics Corp

Filed	Form	Filer	Stake	Shares
2026-08-31	SCHEDULE 13D/A	5AM Ventures VI, L.P.	9.90%	2,033,270	view →
2026-08-19	SCHEDULE 13D/A	Polaris Management Co. VII, L.L.C.	6.30%	3,023,161	view →
2026-08-05	SCHEDULE 13D/A	5AM Ventures VI, L.P.	9.90%	2,625,145	view →

Other Filings by Enavate Sciences GP, LLC

Filed	Form	Issuer	Stake	Shares
2026-08-19	SCHEDULE 13D/A	Zenas BioPharma, Inc.	4.90%	3,245,404	view →
2025-10-14	SCHEDULE	Zenas BioPharma, Inc. ZBIO	7.30%	3,919,159	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →